GlassScriptPhysician profile
Mary K Hamid
NPI 1588635569
$485.97
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $99.99 · 2021: $38.26 · 2022: $13.79 · 2023: $271 · 2024: $62.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $333.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $99.99 | 2020 | |
| Abbvie INC. | $79.14 | 2021-2023 | |
| Insightec,INC | $51.98 | 2023 | Exablate |
| Baxter Healthcare | $49.60 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Glaxosmithkline, LLC. | $45.56 | 2023 | Shingrix, Arexvy |
| Pfizer INC. | $37.48 | 2024 | |
| Novo Nordisk INC | $31.42 | 2023 | Ozempic, Rybelsus |
| Abbott Laboratories | $25.12 | 2024 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $21.73 | 2023 | |
| Daiichi Sankyo INC. | $17.88 | 2023 | Injectafer |
| Amarin Pharma, INC. | $13.73 | 2021 | |
| Grt US Holding, INC. | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Hamid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.